Loading clinical trials...
Loading clinical trials...
Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying: a Prospective Ultrasound Approach with Focus on Perioperative Aspiration Risk.
Conditions
Interventions
Gastric ultrasound
Start Date
November 1, 2024
Primary Completion Date
October 31, 2026
Completion Date
December 31, 2026
Last Updated
October 26, 2024
NCT07100691
NCT01798342
Michael Ganter Director and Chairman Institute of Anesthesiology and Intensiv, Prof. Dr. med.
CONTACT
+41 44 387 38 80Michael.Ganter@hirslanden.chLead Sponsor
Sascha Battig
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions